Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Early research (Phase 1)Study completedNCT00959933
What this trial is testing

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Who this might be right for
Chronic Hepatitis C
Sandoz 24
Post-approval studies (Phase 4)Study completedNCT00707850
What this trial is testing

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

Who this might be right for
Hepatitis CThalassemia
Baqiyatallah Medical Sciences University 300
Testing effectiveness (Phase 2)Study completedNCT02340962
What this trial is testing

Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 25
Not applicableStudy completedNCT02583243
What this trial is testing

Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

Who this might be right for
Opioid-related DisordersHIV InfectionsHepatitis C, Chronic+1 more
Yale University 209
Not applicableStudy completedNCT02760355
What this trial is testing

Extrahepatic Insulin Resistance in Chronic Hepatitis C

Who this might be right for
Insulin Resistance
University Hospital, Geneva 17
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Post-approval studies (Phase 4)Study completedNCT00375661
What this trial is testing

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Who this might be right for
Hepatitis C, Chronic
Kyoto University 100
Large-scale testing (Phase 3)Study completedNCT00302081
What this trial is testing

Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 696
Large-scale testing (Phase 3)Study completedNCT02219477
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

Who this might be right for
Chronic Hepatitis CDecompensated CirrhosisHepatitis C Virus
AbbVie 36
Not applicableStudy completedNCT02850289
What this trial is testing

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Post-approval studies (Phase 4)Study completedNCT00351871
What this trial is testing

Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy

Who this might be right for
Chronic Hepatitis C
Louisiana State University Health Sciences Center in New Orleans 400
Testing effectiveness (Phase 2)WithdrawnNCT01629732
What this trial is testing

Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00695019
What this trial is testing

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 169
Large-scale testing (Phase 3)WithdrawnNCT01890200
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp.
Next Page